Gabapentin Dementia Lawsuit in Wisconsin - Free Case Review

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Key Takeaway

Wisconsin has taken proactive regulatory action on gabapentin, classifying it as a Schedule V controlled substance — joining the small group of states that have acknowledged the drug's misuse and dependence potential. Wisconsin's manufacturing economy — dairy processing, paper mills, automotive parts, and heavy industry — produces chronic pain rates that drive substantial gabapentin prescribing. The state's opioid crisis hit northern and rural communities particularly hard, with gabapentin emerging as a primary alternative. The Medical College of Wisconsin and the University of Wisconsin Medical Center provide the state's primary neuroscience resources, but rural Wisconsin faces significant specialist shortages. Milwaukee County Circuit Court has experience with pharmaceutical litigation and is the primary state court venue for complex claims.

Written By

People's Justice Legal Research Team

Statute of Limitations

Wisconsin: 3 years for personal injury (Wis. Stat. § 893.54). Discovery rule applies — limitations begin when the plaintiff discovers or should have discovered the injury and its cause.

3 years from discovery of injury

Filing Venue

Where to File in Wisconsin

Wisconsin gabapentin cases may be filed in the Eastern District (Milwaukee) or Western District (Madison). Milwaukee County Circuit Court handles complex pharmaceutical litigation. Wisconsin follows modified comparative fault with a 51% bar. The state caps non-economic damages in medical malpractice but not in product liability cases. Wisconsin classified gabapentin as a Schedule V controlled substance, providing comprehensive PDMP data for litigation. Wisconsin's 3-year SOL provides reasonable filing time.

Wisconsin Data

Exposure in Wisconsin

Source: IQVIA / WI ePDMP data

Source: Wisconsin DSPS / Pharmacy Examining Board

Source: Medical College of Wisconsin / UW Health

FAQ

Frequently Asked Questions

See details below.

Back to Gabapentin Dementia Lawsuit Lawsuit Overview